Just diagnosed with breast cancer — what happens next?

Being told you have breast cancer is a moment that compresses the future into a single sentence. The conversation that follows the diagnosis is full of medical terms, scheduling, and decisions that need to be made faster than feels comfortable. Most patients leave that appointment knowing they have cancer but without a clear picture of the next few weeks.

This piece is for patients who have just had an invasive breast cancer diagnosis — usually after a triple assessment confirmed the cancer on biopsy. It explains what the next four to eight weeks are going to look like before treatment begins.

If your diagnosis is DCIS (ductal carcinoma in situ), the situation and decision-making are different — see the DCIS-specific guide instead. If you have been recalled from screening but no biopsy has been taken yet, see breast cancer screening for what the recall process involves.

What “invasive breast cancer” means

The biopsy that confirmed your diagnosis told the pathologist three things: that breast cancer cells are present, that they are invasive (have grown beyond the duct or lobule they started in), and the type. The type is most commonly invasive ductal carcinoma (also called no special type / NST) or invasive lobular carcinoma. There is a glossary entry on each type if you want the detailed definition.

What you do not yet know — and what the next few weeks are designed to find out — is:

• The stage of the cancer: how big it is, whether it has reached the lymph nodes under the arm, and whether there is any sign it has spread further.
• The biology of the cancer: hormone-receptor status (oestrogen, progesterone), HER2 status, and the grade — three pieces of information that drive almost every treatment decision.
• The treatment plan: surgery first, or chemotherapy first; lumpectomy or mastectomy; whether radiotherapy is needed; what hormone therapy looks like over the years afterwards.

These are the questions of the next four to eight weeks. The pathway is built to answer them in order, then to start treatment with the best information available.

The first 48 hours

Most patients are told the result at a clinic appointment about 1 to 2 weeks after the biopsy. The appointment itself is usually 30 to 60 minutes. A senior consultant gives the diagnosis, a breast care nurse joins the conversation, and at the end you are given written information, a contact number for the breast care nurse team, and a follow-up plan.

The first 48 hours are mostly about absorbing the news rather than acting on it. A few practical things help:

• Tell one or two close people first, not a wide circle. The first conversations are the rawest; you can broaden the circle later when you have a clearer picture yourself.
• Don’t make irreversible decisions in the first 48 hours. There is no operation that has to happen tomorrow. The pathway is built around getting the right information first.
• Write down your questions as they come up, even the ones that feel basic. Take the list to the next appointment. The team is used to long question lists — they expect them.
• Use the breast care nurse contact. The nurse team is the practical interface for everything from “what does this word mean” to “I can’t sleep” to “I’m worried about telling my children.” Their phone number is on the discharge information; use it freely.

The breast cancer charities — Breast Cancer Now and Macmillan in particular — have helplines staffed by trained nurses for exactly this moment. Calling them is not a waste of their time; that is what they are for.

Staging investigations — the next 1 to 3 weeks

Before treatment can be planned, the team needs to know the stage of the cancer. This usually involves some combination of:

Imaging the breast more thoroughly

A diagnostic mammogram, ultrasound, and sometimes MRI will be repeated to map the cancer in detail. That includes its precise size, whether there are additional smaller cancers in the same breast that weren’t seen initially, and the appearance of the other breast. MRI is particularly useful for invasive lobular carcinoma, which can be hard to size on mammography alone.

Imaging the rest of the body

For early-stage cancers, blood tests and a chest X-ray are often sufficient. For larger cancers, cancers that have already shown signs of nodal involvement, or cancers with worrying biology, more thorough staging is done. That is typically a CT scan of chest, abdomen, and pelvis plus a bone scan (sometimes combined as a PET-CT). This is to look for any sign of spread (metastasis); the great majority of these scans are clear.

The waiting time for these scans varies by hospital and pathway. NHS staging is typically completed within 2 to 3 weeks of the diagnosis appointment; private staging is usually within a week. The wait between the scans being done and the results being discussed is often the hardest part of the pathway — short, but anxious.

Lymph node assessment

In many cases the lymph nodes under the arm have already been imaged at the time of the original biopsy (axillary ultrasound, sometimes with a needle biopsy of any abnormal node). If they look normal, the formal nodal staging is done at the time of surgery via sentinel lymph node biopsy. If the imaging or biopsy showed obvious nodal disease, the surgical plan changes accordingly.

The biology report

Alongside the staging investigations, the pathologist works on the biology of the cancer:

• Oestrogen receptor (ER) and progesterone receptor (PR) — see the oestrogen receptor glossary entry. Most invasive breast cancers in the UK are ER-positive, which means hormone therapy will be part of the treatment.
• HER2 status — see the HER2 glossary entry. HER2-positive cancers have effective targeted therapies.
• Grade — how aggressive the cells look under the microscope. See grade and stage for what the numbers mean.

By the end of the staging period, a complete picture is in place: the size, the nodal status, the spread (or absence of spread), and the biology. This is what the multidisciplinary team uses to plan treatment.

The MDT meeting and the treatment-planning conversation

Every breast cancer case in modern UK practice — NHS or private — is reviewed at a multidisciplinary team meeting before treatment is confirmed. The MDT brings together the breast surgeon, oncologist (medical and clinical), radiologist, pathologist, breast care nurse, and (where reconstruction is part of the picture) the plastic surgeon. They review the imaging, the pathology, and the staging together and agree the treatment recommendation.

Within a few days of the MDT, you will have a treatment-planning appointment — usually with your breast surgeon and the breast care nurse — where the recommendation is explained. The questions at this appointment typically include:

“Do I need chemotherapy, and when?”

Some cancers need chemotherapy before surgery (called neoadjuvant chemotherapy); others need it after (adjuvant); others not at all. The decision is driven by the cancer’s biology and stage. If chemotherapy is indicated and is planned before surgery, an appointment with a medical oncologist follows promptly. See the Cancer Research UK page on chemotherapy decisions for an overview. Or use the conversation with your team to walk through your specific picture.

“What kind of surgery?”

The two main paths are breast-conserving surgery (lumpectomy) with radiotherapy afterwards, or mastectomy with or without reconstruction. Both have equivalent long-term survival when each is the right choice for the cancer in question. The factors that drive the decision are the size and position of the cancer, the biology, the patient’s preference, and what reconstructive options are realistic. See the insights piece on the mastectomy-vs-lumpectomy decision for the longer discussion.

“If mastectomy, what about reconstruction?”

Reconstruction is a major decision in its own right. It can be done at the same operation (immediate) or later (delayed). The options are implant-based, autologous (using the patient’s own tissue), or a deliberate flat-closure result. The insights piece on choosing reconstruction and the reconstruction glossary anchor cover the ground; the services pages describe the specific operations.

“What about radiotherapy?”

Radiotherapy is standard after lumpectomy, and for some patients after mastectomy. For most patients in the UK it is now a daily outpatient treatment over 1 week (5 sessions). Some patients have a 3-week (15-session) schedule, particularly where the nodes or reconstruction change the plan. Treatment usually starts several weeks after the surgery has healed. The clinical oncologist will discuss the specifics at a separate appointment.

“What about hormone therapy?”

For ER-positive cancers (the majority), an oral hormone-blocking medication — tamoxifen or an aromatase inhibitor — is taken for 5 to 10 years after the surgery and other initial treatments. This is one of the most effective parts of breast cancer treatment in reducing recurrence risk; the conversation about which medication and for how long is with the medical oncologist.

“What about targeted therapy?”

If the cancer is HER2-positive, targeted antibody treatment (most commonly trastuzumab) is added to the plan, usually for a year. Some patients receive it as part of chemotherapy; others as a stand-alone infusion course. See the HER2 glossary entry.

These conversations spread across two or three appointments rather than one. Most patients leave the first treatment-planning appointment with the broad shape of the plan and the specifics filled in over the following 1 to 2 weeks as the oncology appointments happen.

How long until treatment actually starts?

The typical timeline from diagnosis to first treatment in the UK:

The wait between the diagnosis and the start of treatment is for a reason — staging investigations, the MDT review, and the planning appointments all happen in this window. Faster is not always better: starting treatment with incomplete staging information can mean treatment changes later.

That said, the wait is hard. Two things that help: scheduling-related anxiety is best addressed by the breast care nurse team — they are the people who can give you a realistic timeline for your specific scans and appointments. Cancer-related anxiety is best addressed by talking — to family, to a counsellor, to the breast care nurse, to one of the charity helplines. Both are normal; both have practical answers.

Things you can do in the waiting period

The 4 to 6 weeks between diagnosis and the start of treatment are useful for:

• Getting your house in order — practical things like understanding any insurance cover, arranging time off work, organising childcare or eldercare during planned treatment dates, sorting any travel / commitments that need rescheduling.
• Getting fit — patients who arrive at surgery in better physical shape recover faster. Walking 30 minutes a day, eating well, and sleeping properly are the three things to prioritise. If you smoke, this is the right time to stop — particularly for any patient considering autologous reconstruction. Help with stopping is available through the GP or the breast care nurse.
• Asking questions you didn’t know you had — write them down as they occur. The MDT-planning appointment, the oncologist appointments, and the surgical pre-assessment are all chances to ask. There is no question too basic, and “I don’t know what to ask” is a perfectly fine sentence to start an appointment with.
• Getting a second opinion if you want one. A second opinion at this point is normal, particularly when there is a difficult choice between treatment routes. See the second opinion service for what is involved.
• Setting up support — peer-support groups, online communities (Breast Cancer Now’s Forum, Macmillan’s Online Community), and individual counselling all have a role. The breast care nurse can suggest local options.

What the next 6 to 12 months typically look like

The treatment timeline depends heavily on the specific plan, but a common pattern is:

• Week 0 — diagnosis confirmed.
• Weeks 1 to 4 — staging investigations and MDT review.
• Weeks 4 to 6 — surgery (or first cycle of neoadjuvant chemotherapy if that is the path).
• Months 2 to 5 — radiotherapy if indicated (typically 1 week, or 3 weeks in selected cases); chemotherapy if indicated (typically 4 to 6 months including the targeted antibody phase).
• Months 4 to 12 — recovery, hormone therapy starts, reconstruction (if delayed), and adjuvant treatments continue. By the 12-month mark most patients are back to a full life, with hormone therapy continuing in the background for years afterwards.

This is one shape; many patients have a different sequence. The team will give you a pathway map at the planning appointment that lays out your specific timeline.

What helps in the early weeks

Some things patients consistently say helped:

• One person to come to all the appointments — usually a partner, sibling, or friend. Two people remember conversations better than one. They also catch the questions you forget to ask.
• A notebook for the appointments — written questions in, written answers out. Digital is fine; paper is fine.
• Being honest with the team about what you do and don’t understand. The job of the breast care nurse and surgeon is to make sure you understand what is being decided. Asking them to explain something a third time is reasonable.
• Saying yes to the breast care nurse phone calls even when you feel fine. The check-in calls catch problems early; the nurse is a useful person to have on your side.
• Pacing the news — telling the wider circle of family, friends, and colleagues at your own pace, rather than feeling obligated to inform everyone at once.

What you do not have to do

A few common pressures patients describe that are not actually requirements:

• You do not have to make a treatment decision in the first appointment. The pathway is designed for thinking time. If you need a second appointment to weigh up surgery options, ask for it.
• You do not have to read all of the medical literature — Breast Cancer Now, Cancer Research UK, and Macmillan have patient-grade information that is more useful than searching academic papers in the early weeks.
• You do not have to be brave. “Brave” is not a clinical category; it is a word other people use about you. How you feel during the early weeks is between you and the people you trust.
• You do not have to have a positive attitude. The best available evidence does not support the idea that “positive thinking” meaningfully changes cancer outcome; outcomes depend on the biology of the cancer and the treatment. How you feel during the early weeks is between you and the people you trust.
• You do not have to know yet what kind of patient you want to be in the months ahead. That settles itself over the first few weeks. Most patients find a routine, a tone, and a circle of support that works for them — but not on day one.

How Breastory fits in

For patients seen in the practice — privately or transferring from an NHS pathway — Dr Tsang-Wright is the named consultant from diagnosis through surgery and the long-term follow-up. Sarah or Nadiya, Dr Tsang-Wright’s PAs, coordinate appointment logistics, scheduling, and the practical interface with the hospitals (Chelsea, Harley Street, Buckinghamshire). The breast care nurse team works alongside the surgical practice and is contactable directly.

If you are reading this on the morning after your diagnosis and want to talk through a private route — whether for the full pathway or for a specific second-opinion or planning consultation — contact Sarah or Nadiya at [email protected] or 07785 274 744. Same-week appointments are usually available.

If you are on an NHS pathway and reading this for context, the same information applies — your team will deliver the same standard of care, the same MDT process, and the same biology-driven treatment decisions. See the NHS or private comparison if you are weighing whether to move between routes.